POINT VISION acquired by ARES & BPIFRANCE
Context
Ares Management acquired a majority stake in Point Vision following a highly competitive auction process (beating Adagia, Ramsay, and Elsan). Bpifrance joined as a minority shareholder alongside Ares and the three founders who reinvested. Abenex, which entered in 2014 and held the majority since 2019, fully exited. The financing was secured through a unitranche facility provided by Tikehau Capital. The strategy focuses on expanding territorial coverage (especially in Auvergne-Rhone-Alpes and Ile-de-France) and digitizing the patient journey.
POINT VISION, which reported an EBITDA margin of [members only] in 2021, is valued in this transaction at an EV/EBITDA multiple of Above 20x, representing a premium to the average currently observed in the Healthcare & Pharma sector (14.3x).
-> Deep-dive in Healthcare & Pharma market trends
Target
Point Vision is the leading operator of ophthalmology centers in France. Founded in 2012 by Dr. François Pelen, Patrice Pouts, and Raphael Schnitzer, the group was created to address a critical structural issue in the French healthcare system: the extreme shortage of ophthalmologists and the resulting excessive waiting times for appointments (often 3 to 6 months).
Ent. Value
€300–700M
Equity Value
[members only]
Multiples
EV / Revenue
2x–6x
EV / EBITDA
Above 20x
EV / EBIT
[members only]
Historical Financials (EUR)
Other operations with POINT VISION
Other operations with POINT VISION
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 01/2026 | POINT VISION | CLINIQUE DE LA VISION (REFRACT SAS) | FRANCE | Ophthalmology |
Similar deals in Health Providers
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 12/2021 | VIVALTO PARTNERS / IK PARTNERS / MACSF / ARKEA CAPITAL / BNP PARIBAS DEVELOPPEMENT | VIVALTO SANTÉ | FRANCE | Clinics / Hospitals |
| 11/2021 | CERBA HEALTHCARE | LABEXA | FRANCE | Labs (Biology) |
| 10/2021 | THE CRANEMERE GROUP | OUTPATIENT IMAGING AFFILIATES | UNITED STATES | Radiology |
| 10/2021 | IVC EVIDENSIA | VETONE | FRANCE | Vet Clinics |
| 09/2021 | LIVINGBRIDGE | EVERLIGHT RADIOLOGY | UNITED KINGDOM | Radiology |
| 08/2021 | COLOSSEUM DENTAL GROUP | CURAEOS | NETHERLANDS | Dental Centers |
| 07/2021 | EQT PARTNERS | BLIKK GROUP | GERMANY | Radiology |
| 07/2021 | EQT PARTNERS | MEINE RADIOLOGIE | GERMANY | Radiology |
| 07/2021 | WREN HOUSE | ALMAVIVA SANTÉ | FRANCE | Clinics / Hospitals |
| 07/2021 | OMERS | AMEDES | GERMANY | Labs (Biology) |
Other operations with ARES / BPIFRANCE
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 03/2026 | ARES | EUROPASTRY | SPAIN | Bakery / Pastry |
| 06/2025 | ARES | PLENITUDE | ITALY | Renewables |
REFERENCES
Valuation range: EV €300–700M
Revenue range: €50–100M
EBITDA range: €5–25M
EV/Revenue range: 2x - 6x
EV/EBITDA range: Above 20x
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of POINT VISION by ARES / BPIFRANCE are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Target: point vision